Compare $GRI vs $ORGS | Chartloom

Compare

$GRI vs $ORGS

GRI Bio Inc · Orgenesis Inc

GRI

GRI Bio Inc

ORGS

Orgenesis Inc

Compare $GRI vs $ORGS

Comparing GRI Bio Inc and Orgenesis Inc

GRIGRI Bio Inc

ORGSOrgenesis Inc

GRIGRI Bio Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-77.8%

52W performance

-96.7%

FCF yield

-338.3%

ORGSOrgenesis Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.8%

YTD performance

133.3%

52W performance

-56.3%

FCF yield

-505.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GRI

ORGS

Detailed metrics comparison

GRI

GRI Bio Inc

ORGS

Orgenesis Inc

Market Cap

GRI$3M

ORGS$3M

Enterprise Value

GRI$-8M

ORGS$20M

Price

GRI$1.74

ORGS$0.35

P/E Ratio

GRIN/A

ORGSN/A

P/S Ratio

GRI0.00x

ORGS3.31x

EV/Sales

GRI0.00x

ORGS19.39x

EV/EBITDA

GRI0.00x

ORGS0.00x

P/B Ratio

GRI0.42x

ORGS0.28x

P/FCF Ratio

GRIN/A

ORGSN/A

EV/FCF

GRI0.76x

ORGS-1.16x

PEG Ratio

GRIN/A

ORGSN/A

Forward P/E (NTM)

GRIN/A

ORGSN/A

Forward P/S (NTM)

GRIN/A

ORGSN/A

Revenue (TTM)

GRI$0

ORGS$1M

Revenue Growth (YoY)

GRIN/A

ORGS-92.8%

Forward Rev Growth

GRI0.0%

ORGS0.0%

Gross Margin (TTM)

GRI0.0%

ORGS-86.3%

Operating Margin (TTM)

GRI0.0%

ORGS0.0%

EBITDA Margin (TTM)

GRI0.0%

ORGS-1868.2%

Net Margin (TTM)

GRI0.0%

ORGS-4653.6%

FCF Margin (TTM)

GRIN/A

ORGS-1675.3%

Net Income (TTM)

GRI$-10M

ORGS$-48M

FCF (TTM)

GRI$-10M

ORGS$-17M

EPS (TTM)

GRI-$5.35

ORGS-$9.58

ROE (TTM)

GRI-13403.0%

ORGS-10936.0%

ROA (TTM)

GRI-10683.0%

ORGS-20820.0%

ROIC (TTM)

GRI-13403.0%

ORGS-5864.0%

Cash

GRI$11M

ORGS$78K

Debt

GRI$0

ORGS$17M

Net Cash/Debt

GRI$11M

ORGS$-17M

Current Ratio (TTM)

GRI10.30x

ORGS0.03x

Quick Ratio (TTM)

GRI9.95x

ORGS0.03x

Debt/Equity (TTM)

GRI0.00x

ORGS1.73x

Debt/Assets (TTM)

GRI0.0%

ORGS0.0%

Interest Coverage (TTM)

GRIN/A

ORGSN/A

Net Debt/EBITDA (TTM)

GRI0.00x

ORGS0.00x

Beta

GRI-1.09

ORGS3.73

52W Performance

GRI-96.7%

ORGS-56.3%

YTD Performance

GRI-77.8%

ORGS133.3%

% from 52W High

GRI-97.3%

ORGS-65.0%

% from 52W Low

GRI27.9%

ORGS34900.0%

Asset Turnover (TTM)

GRI0.00x

ORGS0.04x

FCF Yield (TTM)

GRI-338.3%

ORGS-505.5%

Earnings Yield (TTM)

GRI-313.6%

ORGS-1404.2%

Dividend Yield (TTM)

GRIN/A

ORGSN/A

Rule of 40

GRI0.0

ORGS-1,768.0

EV/GP/RG

GRIN/A

ORGSN/A

Ticker research

View GRI research View ORGS research

Metric	GRI GRI Bio Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$-8M	$20M
Price	$1.74	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.31x
EV/Sales	0.00x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.42x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	0.76x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-92.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-86.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1868.2%
Net Margin (TTM)	0.0%	-4653.6%
FCF Margin (TTM)	N/A	-1675.3%
Net Income (TTM)	$-10M	$-48M
FCF (TTM)	$-10M	$-17M
EPS (TTM)	-$5.35	-$9.58
ROE (TTM)	-13403.0%	-10936.0%
ROA (TTM)	-10683.0%	-20820.0%
ROIC (TTM)	-13403.0%	-5864.0%
Financial Health
Cash	$11M	$78K
Debt	$0	$17M
Net Cash/Debt	$11M	$-17M
Current Ratio (TTM)	10.30x	0.03x
Quick Ratio (TTM)	9.95x	0.03x
Debt/Equity (TTM)	0.00x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.09	3.73
52W Performance	-96.7%	-56.3%
YTD Performance	-77.8%	133.3%
% from 52W High	-97.3%	-65.0%
% from 52W Low	27.9%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-338.3%	-505.5%
Earnings Yield (TTM)	-313.6%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,768.0
EV/GP/RG	N/A	N/A
Ticker research	View GRI research	View ORGS research

Valuation

P/S Ratio

GRI

0.00x

ORGS

3.31x

EV/FCF

ORGS

-1.16x

GRI

0.76x

Growth & revenue

Revenue Growth TTM

ORGS

-92.8%

Forward Revenue Growth

GRI

0.0%

ORGS

0.0%

Profitability & performance

Gross Margin

GRI

0.0%

ORGS

-86.3%

ROE

ORGS

-10936.0%

GRI

-13403.0%

FCF Yield %

GRI

-338.3%

ORGS

-505.5%

52-Week Performance

ORGS

-56.3%

GRI

-96.7%

Detailed metrics comparison

GRI

GRI Bio Inc

ORGS

Orgenesis Inc

Market Cap

GRI$3M

ORGS$3M

Enterprise Value

GRI$-8M

ORGS$20M

Price

GRI$1.74

ORGS$0.35

P/E Ratio

GRIN/A

ORGSN/A

P/S Ratio

GRI0.00x

ORGS3.31x

EV/Sales

GRI0.00x

ORGS19.39x

EV/EBITDA

GRI0.00x

ORGS0.00x

P/B Ratio

GRI0.42x

ORGS0.28x

P/FCF Ratio

GRIN/A

ORGSN/A

EV/FCF

GRI0.76x

ORGS-1.16x

PEG Ratio

GRIN/A

ORGSN/A

Forward P/E (NTM)

GRIN/A

ORGSN/A

Forward P/S (NTM)

GRIN/A

ORGSN/A

Revenue (TTM)

GRI$0

ORGS$1M

Revenue Growth (YoY)

GRIN/A

ORGS-92.8%

Forward Rev Growth

GRI0.0%

ORGS0.0%

Gross Margin (TTM)

GRI0.0%

ORGS-86.3%

Operating Margin (TTM)

GRI0.0%

ORGS0.0%

EBITDA Margin (TTM)

GRI0.0%

ORGS-1868.2%

Net Margin (TTM)

GRI0.0%

ORGS-4653.6%

FCF Margin (TTM)

GRIN/A

ORGS-1675.3%

Net Income (TTM)

GRI$-10M

ORGS$-48M

FCF (TTM)

GRI$-10M

ORGS$-17M

EPS (TTM)

GRI-$5.35

ORGS-$9.58

ROE (TTM)

GRI-13403.0%

ORGS-10936.0%

ROA (TTM)

GRI-10683.0%

ORGS-20820.0%

ROIC (TTM)

GRI-13403.0%

ORGS-5864.0%

Cash

GRI$11M

ORGS$78K

Debt

GRI$0

ORGS$17M

Net Cash/Debt

GRI$11M

ORGS$-17M

Current Ratio (TTM)

GRI10.30x

ORGS0.03x

Quick Ratio (TTM)

GRI9.95x

ORGS0.03x

Debt/Equity (TTM)

GRI0.00x

ORGS1.73x

Debt/Assets (TTM)

GRI0.0%

ORGS0.0%

Interest Coverage (TTM)

GRIN/A

ORGSN/A

Net Debt/EBITDA (TTM)

GRI0.00x

ORGS0.00x

Beta

GRI-1.09

ORGS3.73

52W Performance

GRI-96.7%

ORGS-56.3%

YTD Performance

GRI-77.8%

ORGS133.3%

% from 52W High

GRI-97.3%

ORGS-65.0%

% from 52W Low

GRI27.9%

ORGS34900.0%

Asset Turnover (TTM)

GRI0.00x

ORGS0.04x

FCF Yield (TTM)

GRI-338.3%

ORGS-505.5%

Earnings Yield (TTM)

GRI-313.6%

ORGS-1404.2%

Dividend Yield (TTM)

GRIN/A

ORGSN/A

Rule of 40

GRI0.0

ORGS-1,768.0

EV/GP/RG

GRIN/A

ORGSN/A

Ticker research

View GRI research View ORGS research

Metric	GRI GRI Bio Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$3M	$3M
Enterprise Value	$-8M	$20M
Price	$1.74	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.31x
EV/Sales	0.00x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.42x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	0.76x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-92.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-86.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1868.2%
Net Margin (TTM)	0.0%	-4653.6%
FCF Margin (TTM)	N/A	-1675.3%
Net Income (TTM)	$-10M	$-48M
FCF (TTM)	$-10M	$-17M
EPS (TTM)	-$5.35	-$9.58
ROE (TTM)	-13403.0%	-10936.0%
ROA (TTM)	-10683.0%	-20820.0%
ROIC (TTM)	-13403.0%	-5864.0%
Financial Health
Cash	$11M	$78K
Debt	$0	$17M
Net Cash/Debt	$11M	$-17M
Current Ratio (TTM)	10.30x	0.03x
Quick Ratio (TTM)	9.95x	0.03x
Debt/Equity (TTM)	0.00x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.09	3.73
52W Performance	-96.7%	-56.3%
YTD Performance	-77.8%	133.3%
% from 52W High	-97.3%	-65.0%
% from 52W Low	27.9%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-338.3%	-505.5%
Earnings Yield (TTM)	-313.6%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,768.0
EV/GP/RG	N/A	N/A
Ticker research	View GRI research	View ORGS research